Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Publication year range
1.
Diabetes Metab Syndr Obes ; 17: 857-864, 2024.
Article in English | MEDLINE | ID: mdl-38406268

ABSTRACT

Background: The incidence of Type 1 Diabetes Mellitus (T1DM) is on the rise. Since there is no curative treatment, it is urgent to look for therapies that can delay disease progression and protect pancreatic ß-cells. Dipeptidyl peptidase-4 inhibitors (DPP-4i) have shown potential in modulating inflammation and preventing ß-cell destruction. This protocol describes an upcoming trial to evaluate the effectiveness of the DPP-4i alogliptin in delaying the progression of stage 2 (presymptomatic) to stage 3 (symptomatic) T1DM. Patients and Methods: We propose a two-year, two-arm, multicenter, randomized, open-label clinical trial targeting Brazilian patients aged 18 to 35 with stage 2 T1DM. The study, facilitated by the custom-developed "PRE1BRAZIL" web application, aims to enroll 130 participants. They will be randomly assigned in a 1:1 ratio to either a treatment group (alogliptin 25 mg daily plus regular clinical and laboratory assessments) or a control group (regular assessments only). The primary outcome is the rate of progression to stage 3 T1DM. Secondary outcomes include changes in A1c levels, glucose levels during a 2-hour oral glucose tolerance test (OGTT), C-peptide levels, exogenous insulin requirements, Insulin-Dose Adjusted A1c (IDAA1c), and the incidence of diabetic ketoacidosis (DKA) in those advancing to stage 3. Discussion: This protocol outlines the first randomized clinical trial (RCT) to investigate the impact of a DPP-4i in the presymptomatic stage of T1DM. The trial is designed to provide critical insights into the role of DPP-4i in the secondary prevention of T1DM. Utilizing the "PRE1BRAZIL" web application is expected to enhance participant enrollment and reduce operational costs. Registration: Brazilian Registry of Clinical Trials.

2.
Comput Inform Nurs ; 2021 Sep 24.
Article in English | MEDLINE | ID: mdl-34570007

ABSTRACT

The use of simulation for nursing education has several advantages. The present study aimed to develop and validate a serious virtual reality game for medication preparation and administration training. This is a methodological study in which a serious virtual reality game named NurseVR was developed and evaluated by teachers and students of a nursing course. In NurseVR, the player presents himself or herself in a simulated hospital environment to prepare and administer a medication. From then on, all the steps to be taken are the player's free choice according to what was learned in the classroom, making the game the closest to reality. High levels of positive agreement to statements concerning the validity of the game were found between students and teachers. The virtual immersion proposal was an innovative tool, and the validation results of the final version of NurseVR allow its use for nursing training.

3.
Rev Bras Enferm ; 65(1): 155-61, 2012.
Article in Portuguese | MEDLINE | ID: mdl-22751724

ABSTRACT

The study aimed to analyze the aspects of the nursing consultation (NC) in scientific publications. It was conducted an integrative literature review available in databases: LILACS, PUBMED, CINAHL and COCHRANE. 31 articles were selected that met the inclusion criteria. The themes most addressed on the NC were: factors affecting the NC, time and cost of consultations, assessment of nursing records, use of interview scripts, communication, systematization of nursing care, meaning and importance of the NC to promote health. It was concluded that various aspects of nursing consultation are being addressed in the articles analyzed. However, studies are needed to confirm its efficacy.


Subject(s)
Nursing Diagnosis , Referral and Consultation , Humans
SELECTION OF CITATIONS
SEARCH DETAIL
...